public relations - ExL Events

The ONLY Communications Event for Peer Learning and Unparalleled Networking Exclusively for the Life Sciences Community

July 18-19, 2017

13TH

PUBLIC RELATIONS

& COMMUNICATIONS

SUMMIT

Celgene Campus Summit, NJ

PROVIDING A CLEAR PATH FORWARD DURING CHAOTIC TIMES

CONFERENCE CO-CHAIR Julissa Viana Senior Director, Corporate Communications and Global Social Media CELGENE CORPORATION

KEYNOTE PRESENTER Ron Cohen Founder, Chief Executive Officer and President ACORDA THERAPEUTICS

OPENING KEYNOTE Mark J. Alles Chief Executive Officer CELGENE CORPORATION

CONFERENCE CO-CHAIR Wendy Lund Chief Executive Officer GCI HEALTH

Christian Clymer Vice President of Public Affairs PhRMA

Joshua Palau Senior Director Global Partnerships JOHNSON & JOHNSON

ADDRESSING THE BUILDING/ REBUILDING TRUST COST, PRICING AND VALUE TRIFECTA

TELLING PATIENTS’ STORIES

Ambre Morley Senior Director, Product Communications and Patient Relations NOVO NORDISK

UNIFYING THE INDUSTRY

COMMUNICATING DURING LAUNCHES

Lucy Abreu Director of Corporate Communications OTSUKA AMERICA PHARMACEUTICAL, INC.

Jamie Ring Head of Patient Advocacy SPARK THERAPEUTICS, INC.

COLLABORATING WITH MARKETING

ARTICULATING VALUE

Anthony Farina Vice President, Corporate Affairs and Chief Communications Officer CSL BEHRING

STORYTELLING ON A CORPORATE LEVEL

INDUSTRY EXECUTIVES BREAK DOWN WHERE THE INDUSTRY IS, WHERE WE’RE GOING AND HOW TO GET THERE João Nuno Belo Senior Director, Global Therapeutic Area Public Affairs ABBVIE

Sarah Alspach Vice President of U.S. Communications GLAXOSMITHKLINE

2017 EVENT HIGHLIGHTS: __ Never-before-seen presentations that address where the life sciences industry is, where it’s headed and the role communicators will continue to play

__ A dinner at the conclusion of the first conference day allows attendees to continue conversations with speakers, sponsors and fellow conference-goers

__ In-depth discussions on how the industry can effectively communicate how and why drug prices are set as they are and where the revenue goes

__ Industry leaders will share their firsthand experiences via more than eight insightful case studies __ An out-of-industry presentation on the importance of responding with “yes, and”

SPONSORS

MARQUEE PARTNER

__ With more than 150 attendees, this conference is the place to make new connections or reconnect with former contacts

To register,  866-207-6528  www.exlevents.com/PR or  [email protected]

13TH PUBLIC

RELATIONS

& COMMUNICATIONS

SUMMIT

Dear Colleagues, According to a 2016 Harris Poll, only nine percent of consumers in the U.S. think pharmaceutical and biotech companies put patient well-being ahead of profits. Unfortunately, it’s not difficult to understand why — every day

WHO SHOULD ATTEND? This conference is designed for pharmaceutical, biotechnology and medical technology practitioners with responsibilities in the following areas: __ Public/Media Relations

seems to bring a new story that presents life science companies in a negative light. Reports denounce drug prices that increase without clear explanations why, and human interest pieces highlight stories where pharmaceutical companies treat patients unfairly or deny entry into clinical trials, often omitting the explanations behind such decisions. The healthcare industry is also receiving more attention than ever before on the Hill, with both parties in agreement that something has to change. Although life science organizations are curing or better managing more medical conditions than ever before and providing even greater value, it’s hard to communicate these advances in

__ Communications: Corporate, Brand, Internal, External, Integrated, Multichannel __ Marketing

a sincere way that doesn’t come off as being defensive.

__ Public/Government Affairs

The 13th annual Public Relations & Communications Summit is designed to help you address negative (and

__ Public Policy

sometimes inaccurate) perceptions head on, and build upon your company’s reputation by clearly and openly communicating the value you provide. Now more than ever, it’s important that the press and public understand

__ Investor Relations

what the industry does and the good it provides. On behalf of our advisory board and our host for 2017, we look forward to welcoming you to the Celgene campus in Summit, NJ for two days dedicated to strategic thinking, hands-on learning and the unique opportunity to connect with industry colleagues. Sincerely,

Sarah Goldsmith Bryon Main Sarah Goldsmith Bryon Main Senior Conference Director President ExL Pharma ExL Pharma

__ Community/Advocacy Relations __ Strategic Alliances This event is also of interest to agencies and other vendors that support those who work in public relations, public affairs and communication roles at life sciences companies such as communications agencies, publications and data analytics firms.

DISTINGUISHED ADVISORY BOARD MEMBERS Cathy Cantone, Senior Director, Public Relations, Immunology and Inflammation, CELGENE CORPORATION

Andrew Lewis, Head of Communications, Global Medical and Development, ASTELLAS

Karen Carolonza, Managing Partner, GREEN ROOM COMMUNICATIONS

Chris Loder, Senior Director of Worldwide Communications and Head of U.S. Media Relations, BAYER HEALTHCARE

Nikki Copas, Senior Vice President, DNA COMMUNICATIONS Tom Jones, Healthcare Practice Director, KETCHUM

Tierney Saccavino, Executive Vice President, Corporate Communications, ACORDA THERAPEUTICS, INC.

Buddy Scalera, Senior Director of Content Strategy, THE MEDICINES COMPANY Candace Steele Flippin, Vice President, External Communications, ST. JUDE MEDICAL Wendy Lund, Chief Executive Officer, GCI HEALTH

 VENUE INFORMATION ExL Pharma is pleased to bring the PR Summit to Celgene’s campus in Summit, NJ. We would like to express our gratitude to Celgene for opening up its doors and hosting this event in their Summit West conference facility.

CELGENE CAMPUS

Summit West Campus 556 Morris Avenue Summit, NJ 07901 ExL Pharma is reserving a small block of rooms at a hotel nearby. Please visit http://bit.ly/2nRtmlc for additional information.


MEET OUR CONFERENCE CO-CHAIRS AND ESTEEMED SPEAKING FACULTY: CONFERENCE CO-CHAIR Julissa Viana Senior Director, Corporate Communications and Global Social Media CELGENE CORPORATION Julissa Viana is an experienced global healthcare and corporate communications professional with 20 years of success in creating integrated marketing communications programs, public health partnerships and disease awareness campaigns. Julissa has served as a spokesperson for the American Red Cross in Greater New York. She has also served as a board member for various nonprofit organizations, including NAMI NYC. Currently, Julissa is Senior Director, Global Social Media at Celgene Corporation. In this newly created role, Julissa is responsible for the strategy and management of Celgene’s social media activities at the corporate and franchise levels.

CONFERENCE CO-CHAIR Wendy Lund Chief Executive Officer GCI HEALTH Wendy joined GCI Health as Chief Executive Officer in 2010 and is responsible for setting and carrying out a vision for the agency. With almost 30 years of healthcare communications and marketing experience, she puts patients at the center of everything she does. She has worked on preapproval and launch programs with a diverse group of pharmaceutical, biotech and medical technology companies globally and in the U.S., and across a variety of disease categories from the most serious and rare diseases to those affecting millions of consumers in highly competitive categories. Specializing in patient-centered communications, advocacy and disease awareness issues, Wendy has a specific focus on empowering consumers about their health options. Wendy was recently named one of the top 50 Health Influencers by MM&M/ PRWeek, 2016 PRWeek’s True Women Champion of PR, PRNews Professional of the Year, and PRNews Top Women in PR in 2016 and 2017. She was named a finalist for the 2016 PRWeek’s Agency Professional of the Year.



Lucy Abreu, Director of Corporate Communications, OTSUKA AMERICA PHARMACEUTICAL, INC. Robert Allen, Lead, Digital Operations, BRISTOL-MYERS SQUIBB Mark J. Alles, Chief Executive Officer, CELGENE CORPORATION Sarah Alspach, Vice President of U.S. Communications, GLAXOSMITHKLINE Mark Baldry, Vice President of Global Marketing, AMICUS THERAPEUTICS Jack Barrette, CEO, WEGO HEALTH Suzanne Barston, Manager, Content Producer, Storylab, ABBVIE João Nuno Belo, Senior Director, Global Therapeutic Area Public Affairs, ABBVIE Cathy Cantone, Senior Director, Public Relations, Immunology and Inflammation, CELGENE CORPORATION Larry Cardarelli, Vice President, MULTIVU PRODUCTION, A DIVISION OF PR NEWSWIRE Christian Clymer, Vice President of Public Affairs, PhRMA Dan Cohen, Chair, ABUSE DETERRENT COALITION, Executive Vice President, Government and Public Relations, KEMPHARM, INC. Ron Cohen, M.D., Founder, Chief Executive Officer and President, ACORDA THERAPEUTICS Valerie Delva, Senior Vice President, Health Strategy North America, KETCHUM Jill Dosik, Global President, Scientific Communications and Message Impact, GCI HEALTH Zoe Dunn, Principal, HALE ADVISORS Anthony Farina, Vice President, Corporate Affairs and Chief Communications Officer, CSL BEHRING

Kim Fox, Communications Leader, Office of the Chief Medical Officer (OCMO) Strategic Platforms & Enterprise Scientific Policy, JOHNSON & JOHNSON Mary Halliwell, Senior Director, Content and Channel Management, North America Communications, SANOFI U.S. Kasia Hein-Peters, Vaxelis Head of Marketing, SANOFI PASTEUR Lance Hill, Chief Executive Officer, WITHIN3 Stefani Klaskow, Head of Industry, Healthcare, GOOGLE Becky Lauer, Executive Vice President, Media, GCI HEALTH Wendy Lund, Chief Executive Officer, GCI HEALTH Linda Mayer, Senior Communications Consultant, GREEN ROOM SOLUTIONS Lauren McCurdy, Lead Medical Producer, MULTIVU, A DIVISION OF PR NEWSWIRE Ambre Morley, Senior Director, Product Communications and Patient Relations, NOVO NORDISK Agatha Newman, Associate Director, Medical and Development Communications, ASTELLAS John Nosta, President, NOSTALAB Rebekah Pajak, Project Manager StoryLab Content Development, ABBVIE Joshua Palau, Senior Director Global Partnerships, JOHNSON & JOHNSON Chad Parizman, Head of Social Media and Digital Communications, PFIZER INC. Gregg Pane, MD, MPA, Senior Director, Health Care Affairs,ASSOCIATION OF AMERICAN MEDICAL COLLEGES (AAMC) Sara Pellegrino, Senior Director of Investor Relations and Corporate Communications, AMICUS THERAPEUTICS

EXL PHARMA’S NETWORKING DINNER

SEE WHAT PAST PR SUMMIT PARTICIPANTS HAVE TO SAY ABOUT THE EVENT.

The number one reason past delegates have said they attend the PR Summit is the networking opportunities. Based on this feedback and back by popular demand, we’ve created the ExL Pharma Networking dinner to bring together industry peers for a night of drinks, dinner and dialog. This dinner is open to all conference attendees* looking to network and engage in casual conversation with other like-minded professionals. There’s no agenda or assigned seating, so you can discuss whatever with whomever!

“It was a wonderful experience and all the panels were so topical! It had been too long since I had attended a professional meeting and this one was perfect as it was focused on biotech/pharma. I made a number of wonderful new contacts and caught up with some old acquaintances.” —Senior Director, Corporate Communications, NAVIDEA BIOPHARMACEUTICALS “Excellent and engaging presentations.” —Senior Marketing and Communications Associate, STRYKER CORPORATION “It’s really important to have this conference as it’s the only forum where it is just us in public relations and communications where we can share information, share best practices.” —Director, Public Relations, Immunology and Inflammation, CELGENE CORPORATION “One of the best I’ve been to.” —PR Director, SANOFI PASTEUR “Great meeting!” —Executive Director, PR, BOEHRINGER INGELHEIM “Great energy, great info!” —Manager, Corporate Reputation and Social Media, SANOFI U.S.

Jamie Ring, Head of Patient Advocacy, SPARK THERAPEUTICS, INC. Marie Rosenthal, NATIONAL HEALTHCARE TRADE EDITOR AND REPORTER Matt Ruth, Senior Public Relations, US & Global, ALMAC GROUP Tierney Saccavino, Executive Vice President, Corporate Communications, ACORDA THERAPEUTICS Jennifer Saputo, Associate Director, Employee Communications, ASTELLAS Buddy Scalera, Senior Director of Content Strategy, THE MEDICINES COMPANY Madeleine Shin, Vice President, Media, DNA COMMUNICATIONS Karen Tilstra, Ph.D., Co-Founder, FLORIDA HOSPITAL INNOVATION LAB; Founder, ORLANDO MAGIC INNOVATION LAB Gloria Vanderham, Global Head, Social and Digital Media, NOVARTIS ONCOLOGY Julissa Viana, Senior Director, Corporate Communications and Global Social Media, CELGENE CORPORATION Susan Wagner, Senior Coordinating Medical Unit Producer, NBC NEWS Arlene Weintraub, NATIONAL HEALTHCARE AND PHARMACEUTICAL BUSINESS REPORTER Rose Weldon. Director, R&D ImmunoOncology Communications, BRISTOLMYERS SQUIBB Lisa Wolfe, Global Client Service Leader, GREEN ROOM COMMUNICATIONS Paul Wynn, Oncology & Rare Disease Public Relations, BOEHRINGER INGELHEIM

Fiorino Ristorante 38 Maple St Summit, NJ 07901





*Additional registration is required.

CONTINUE THE CONVERSATION Follow us on Twitter and LinkedIn.

#ExLPRSummit @ExLPharmaPR



ExL Pharma PR & Communications Summit Group

SPONSORSHIP AND EXHIBITION OPPORTUNITIES

Now entering its 13th year, the Public Relations & Communications Summit is the leading industry event for public affairs and communication executives in the life sciences field. For information on the sponsorship and exhibition opportunities available at this conference, please contact Jayson Mercado at 212-400-6236 or [email protected].


TUESDAY, JULY 18, 2017 // DAY ONE 7:30

Registration and Morning Coffee

8:30

Opening Remarks Julissa Viana, Senior Director, Corporate Communications and Global Social Media, CELGENE CORPORATION

8:45

KEYNOTE Keeping Pace in a Changing Healthcare Landscape [[ Review the current state of the industry and how we got here [[ Discuss Celgene’s focus on taking a truly patient-centric approach to drug discovery, development and commercialization [[ Highlight the role communications plays in spreading the word about how the industry is changing the course of human health Mark J. Alles, Chief Executive Officer, CELGENE CORPORATION

9:30

CASE STUDY Communicate Value and Innovation in a Way that Resonates [[ Know your customer(s) and ensure two-way communication [[ Understand how your stakeholders define value now and how their definition may evolve in the future [[ Communicate a value proposition that resonates with stakeholders on an emotional level — internally and externally Anthony Farina, Vice President, Corporate Affairs and Chief Communications Officer, CSL BEHRING

10:00

Networking and Refreshment Break

10:30

PANEL Lessons Learned from the Vaccines Front: How to Effectively Address Fake News [[ Develop a long-term strategy to correct misinformation and reinforce key messages [[ Analyze the roles of key stakeholders [[ Strategize how to maintain readiness in your ability to address fake news Moderator: Madeleine Shin, Vice President, Media, DNA COMMUNICATIONS

strategy enriches company, but infuriates patients and lawmakers,” “Cancer patient, outraged by sky-high drug prices, organizes others to fight them,” “Drug goes from $13.50 a tablet to $750, overnight.” The biopharmaceutical industry is in a crisis and must take action to regain its credibility and reputation. Join Dr. Cohen in a moderated discussion in which he provides his insights on where industry pricing models are heading, the potential for legislative action, and what companies must do to reestablish trust with the public and patient communities they serve. Ron Cohen, M.D., Founder, Chief Executive Officer and President, ACORDA THERAPEUTICS Interviewed by: Tierney Saccavino, Executive Vice President, Corporate Communications, ACORDA THERAPEUTICS 2:30


3:00

Credibility and Authenticity in Today’s Influencer and Gatekeeper Environment [[ Review the current state of health influencer engagement [[ Consider what credibility means as we look toward healthcare in 2020 and the role of influencers [[ Identify the emerging set of gatekeepers vs. influencers in healthcare today and how to authentically mobilize/engage them Valerie Delva, Senior Vice President, Health Strategy North America, KETCHUM Jack Barrette, CEO, WEGO HEALTH John Nosta, President, NOSTALAB

3:30

PANEL Discuss Strategies to Build or Rebuild Trust Internally and Externally [[ Explore the industry’s reputation as a whole and discuss how it impacts individual organizations [[ Understand the importance of employee trust, both in company morale and as they speak to others about the organization [[ Provide the press and public with a more open view of your organization to convey a sense of accessibility and pride Moderator: Zoe Dunn, Principal, HALE ADVISORS

Stefani Klaskow, Head of Industry, Healthcare, GOOGLE Kasia Hein-Peters, Vaxelis Head of Marketing, SANOFI PASTEUR Gregg Pane, MD, MPA, Senior Director, Health Care Affairs, ASSOCIATION OF AMERICAN MEDICAL COLLEGES (AAMC) 11:15

CASE STUDY Going Boldly: Balancing the Public Narrative on Biopharmaceutical Innovation [[ Communicate the fact that we’re in a new era of medicine with better tools and more advanced treatments than ever before [[ Utilize paid advertising to complement organic public affairs efforts [[ Learn how PhRMA is working to bring together all key stakeholders to take a more value-focused approach to healthcare, including by facilitating discussions around value-based contracting [[ Take a collaborative approach to combat some of the major industry challenges by bringing together stakeholders, such as payers, the pharmaceutical industry and government entities Christian Clymer, Vice President of Public Affairs, PhRMA

Sarah Alspach, Vice President of U.S. Communications, GLAXOSMITHKLINE Mary Halliwell, Senior Director, Content and Channel Management, North America Communications, SANOFI U.S. Chad Parizman, Head of Social Media and Digital Communications, PFIZER INC. Matt Ruth, Senior Public Relations, US & Global, ALMAC GROUP 4:15

Optimize Stakeholder Engagement Programs with Online Discussion Platforms [[ Take a look at modern and emerging venues for engaging stakeholders and removing communications barriers [[ Discover trends and tips on how to maximize program results through digital avenues [[ Examine key examples of recent innovations within varying-size programs Lance Hill, Chief Executive Officer, WITHIN3

4:45

KEYNOTE Learn, Unlearn and Relearn: Harness Your Creativity to Stay Relevant in Today’s Evolving Environment Disruption is more than just a buzzword — it’s the name of the game in today’s world. Only those who can adapt to this rate of change will remain relevant. To quote Alvin Toffler, “Tomorrow’s illiterate will not be one who cannot read or write but one who can’t learn, unlearn and relearn.” Learn how to infuse this new mindset into your professional and personal life to keep you relevant and sustainable in these disruptive times. Karen Tilstra, Ph.D., Co-Founder, FLORIDA HOSPITAL INNOVATION LAB; Founder, ORLANDO MAGIC INNOVATION LAB

5:30

Evening Reception, sponsored by

6:30

Evening Reception Concludes

7:00

ExL Pharma’s Networking Dinner

9:30

Conference Day One Concludes

12:00 Luncheon 1:00

1:45

PANEL Communications in Chaotic Times: Providing a Clear Path for Successful Media Engagement Today’s (always) transforming newsrooms, coupled with unpredictable and unorthodox events coming out of DC and elsewhere, have created a true perfect storm for the practice of media relations. In 2017 and beyond, communicators are facing increased challenges around how to best navigate our current media environment, break through with the right story at the right time, and get reporters to talk about “what really matters.” Moderator: Jill Dosik, Global President, Scientific Communications and Message Impact, GCI HEALTH Susan Wagner, Senior Coordinating Medical Unit Producer, NBC NEWS Arlene Weintraub, NATIONAL HEALTHCARE AND PHARMACEUTICAL BUSINESS REPORTER Marie Rosenthal, NATIONAL HEALTHCARE TRADE EDITOR AND REPORTER Becky Lauer, Executive Vice President, Media, GCI HEALTH KEYNOTE From “Most Admired” to “Pharma Bros”: How Biopharmaceutical Companies Have Allowed the Debate on Drug Pricing to Steal Their Reputation – and What Communications Professionals Can Do to Help Get It Back In the 1980s and 1990s, Merck was ranked the most admired company in America seven years in a row. Compare that to today’s headlines: “Drug price

WEDNESDAY, JULY 19, 2017 // DAY TWO 8:00

Registration and Morning Coffee

PATIENT PARTICIPATION

COMMUNICATION EVOLUTION

CREATIVITY DEVELOPMENT

9:00

Effectively Use Social Media to Tell Your Brand Story [[ Learn how social media can shape your company’s communication goals [[ Optimize content across social platforms [[ Demonstrate the value of social media to key stakeholders [[ Partner with enterprise teams to ensure compliant messaging across platforms Chad Parizman, Head of Social Media and Digital Communications, PFIZER INC.

CASE STUDY Differentiate the Roles of Marketing and Corporate Communications [[ Understand the regulatory impact of launching a commercial product and how it impacts communications [[ Walk through how Amicus built a marketing team to prepare for their product launch after previously only having an investor relations/corporate communications department [[ Define who owns which communication initiatives to ensure everyone is held accountable [[ Determine which agency (corporate communications or marketing) should handle different initiatives [[ Collaborate — when it is appropriate — to align on key communications themes, coordinate internal and external messaging, share best practices, and decrease the likelihood of duplicative work Sara Pellegrino, Senior Director of Investor Relations and Corporate Communications, AMICUS THERAPEUTICS Mark Baldry, Vice President of Global Marketing, AMICUS THERAPEUTICS

Explore the Unspoken Skill of Communications: Fundraising [[ Discuss the unfortunate reality that communications’ role is to “sell” PR to various brand teams in order to have access to funds they need to do their jobs [[ Discover innovative ways to navigate and overcome the hurdles of internal fundraising [[ Review tactics that have worked for others in the past when trying to secure funding Moderator: Lisa Wolfe, Global Client Service Leader, GREEN ROOM COMMUNICATIONS Cathy Cantone, Senior Director, Public Relations, Immunology and Inflammation, CELGENE CORPORATION Kim Fox, Communications Leader, Office of the Chief Medical Officer (OCMO) Strategic Platforms & Enterprise Scientific Policy, JOHNSON & JOHNSON Linda Mayer, Senior Communications Consultant, GREEN ROOM SOLUTIONS

9:45

CASE STUDY Meaningful Storytelling: Work with Patients to Drive Awareness and Engagement [[ Identify patients (everyday and celebrity) to tell their stories in unique and novel ways [[ Define the role social media will play in telling and retelling patient stories [[ Determine when branded or disease awareness is best aligned with your company goals (and how to fluidly move between them) [[ Empower patients to take an active role in managing their health and become advocates for their conditions when speaking to government officials, healthcare providers, and other patients and caregivers Ambre Morley, Senior Director, Product Communications and Patient Relations, NOVO NORDISK

CASE STUDY Reach the Asian American Community through Integrated Marketing Communications [[ Engage the Asian American media and community through a culturally-informed approach [[ Integrate PR, marketing, sales, advocacy for a coordinated multi-pronged outreach [[ Overcome potential language barriers by engaging Asian medical experts and using in-language print and digital content Paul Wynn, Oncology & Rare Disease Public Relations, BOEHRINGER INGELHEIM

CASE STUDY Evolve Your Company’s Storytelling Voice to Better Reflect Your Company and Its Values [[ Understand the importance of having a strong voice that’s well-aligned with your organization [[ Develop a guide to share across the organization to ensure a consistent voice companywide [[ Explore specific ways AbbVie is bringing their voice to life Rebekah Pajak, Project Manager StoryLab Content Development, ABBVIE

10:30

Suzanne Barston, Manager, Content Producer, Storylab, ABBVIE


150+

ATTENDEES

25+

SESSIONS

45+

SPEAKERS

INVALUABLE NETWORKING

Including a dinner at the conclusion of the first conference day that allows for continued conversations with speakers, sponsors and other conference attendees


WEDNESDAY, JULY 19, 2017 // DAY TWO 11:00

Leverage within Social Listening to Drive Marketing Best Practices [[ Discuss how social listening can be used when developing and refining your communications strategy [[ Share best practices for setting metrics and tracking ROI to determine if a campaign is successful [[ Partner with marketing to build a more integrated communications strategy Joshua Palau, Senior Director Global Partnerships, JOHNSON & JOHNSON

Reimagine Your Global Corporate Digital Presence [[ Galvanize internal stakeholders around a common digital strategy [[ Reinvent the editorial approach to reestablish the corporate voice with distinction [[ Align people, processes and technologies to manage a global rollout of a digital strategy and platform Robert Allen, Lead, Digital Operations, BRISTOL-MYERS SQUIBB

11:30

CASE STUDY Address Patient Needs Through Social Media [[ Work with patient advocates to understand their needs so you can develop a program to meet those needs [[ Disseminate engaging content developed with patients’ input via social channels and your website to tell a story Gloria Vanderham, Global Head, Social and Digital Media, NOVARTIS ONCOLOGY

Evolve Your Internal Communications: Driving Growth and Creating Culture Change [[ Be empowered as an internal communication leader to drive growth and create culture change by advancing collaboration throughout your organization [[ Position yourself as a leader within the company and demonstrate value throughout the process [[ Create collaboration and trust within your organization (both with communications teams and through business partners) [[ Enable employees and leaders to tell meaningful stories [[ Effectively demonstrate the value of a strong internal communication strategy Agatha Newman, Associate Director, Medical and Development Communications, ASTELLAS

CASE STUDY Utilize Videos to Create More Engaging Content [[ Delve into the benefits video has over other media, such as the ability to evoke emotion and tell a clear story [[ Create a strategy for integrating video content across channels in a meaningful way [[ Examine metrics for measuring the effectiveness of video Lauren McCurdy, Lead Medical Producer, MULTIVU, A DIVISION OF PR NEWSWIRE Rose Weldon, Director, R&D Immuno-Oncology Communications, BRISTOL-MYERS SQUIBB Larry Cardarelli, Vice President, MULTIVU PRODUCTION, A DIVISION OF PR NEWSWIRE CASE STUDY Develop a Corporate Reputation when Launching Your First Product [[ Discuss how to best partner with advocates when there may not be a specific advocacy group for your intended population [[ Break into a disease community that has previously been focused on tools to maintain, instead of treat, a condition [[ Develop programs that provide value to a broader audience [[ Take a truly patient-centric approach to content creation and distribution to make sure it’s accessible to your audience Jamie Ring, Head of Patient Advocacy, SPARK THERAPEUTICS, INC.

Jennifer Saputo, Associate Director, Employee Communications, ASTELLAS 11:45

Luncheon

12:45

Plenary Sessions Opening Remarks Wendy Lund, Chief Executive Officer, GCI HEALTH

1:00

Inspire Innovative Communications in Healthcare Organizations that Believe the Earth Is Flat Large organizations can be slow to change. Often decisions are made using traditional thinking, even when knowledge, technology and tools have evolved. Key stakeholders are reluctant to embrace innovative new ways to share health messages with patients and physicians because they are comfortable with their view of the world. For generations, explorers believed the world was flat. Now digital pioneers are challenging traditional thinking and exploring new worlds. [[ Prepare to address the concerns of leaders who believe the world is flat and do not want to fall off the face of the earth [[ Improve the ways digital strategy is presented and considered in large healthcare organizations [[ Introduce new ideas and suggest changes in an organization not necessarily ready for them [[ Drive small wins that lead to larger victories where others have failed Buddy Scalera, Senior Director of Content Strategy, THE MEDICINES COMPANY

1:45

CASE STUDY Communicate the Strengths of a New Product when Its Benefits Are Difficult to Measure via an Industry Association [[ Understand how the Abuse Deterrent Coalition builds a sound medical, public policy and ultimately commercial case for abuse deterrent technology [[ Strategize how to communicate scientific information to regulatory decision-makers, prescribers and consumers who may not have clinical backgrounds [[ Identify how to best communicate with payers when those developing the formulary are most focused on the cost of the product and are less likely to understand the long-term benefits to the plan of abusedeterrent products

Understand the challenges abuse deterrent innovators faces when discussing a new product that prevents abuse, which is a huge yet unmeasurable benefit Dan Cohen, Chair, ABUSE DETERRENT COALITION, Executive Vice President, Government and Public Relations, KEMPHARM, INC. [[

2:30


3:00

Understand the Communicator’s Role in the Cost, Pricing and Value Dilemma [[ Discuss why communicators are typically not a part of the discussion around price, cost and value [[ Explore how to play an efficient role in this discussion, especially on a global scale [[ Uncover the communicator’s role in framing the notions of cost, pricing and value [[ Understand how this discussion may evolve in the future in the U.S. and around the world João Nuno Belo, Senior Director, Global Therapeutic Area Public Affairs, ABBVIE

3:30

Don’t Be #BASIC when You Can #SLAY “Hello, it’s me. I was wondering if after all these years you’d like to…” NO COMMENT. PR and corporate communications teams around the world, let’s move past #IAintSorry and say “hello from the other side.” OWN your corporate story. Leverage your corporate culture, employee stories and executive thought leaders to hit the top of the communication charts. Together, we will take those traditional plans and antiquated methods and #ShakeItOff. Connect with your internal and external audiences from campaigns to social media strategy to PR in a fun, creative and strategic manner. It’s all one narrative waiting to be shared like #24KMagic. Lucy Abreu, Director of Corporate Communications, OTSUKA AMERICA PHARMACEUTICAL, INC.

4:15

Conference Concludes


 WAYS TO REGISTER 

866-207-6528



www.exlevents.com/PR

@

[email protected]



ExL Events 494 8th Ave, Fourth Floor New York, NY 10001



888-221-6750

REGISTRATION FEES

MEDIA PARTNERS

EARLY BIRD PRICING REGISTER BY JUNE 9, 2017 Conference — Pharma/Biotech/Medical Technology

$1,695

Conference — Agencies/Solution Providers

$1,895

Conference + Dinner — Pharma/Biotech/Medical Technology

$1,845

Conference + Dinner — Agencies/Solution Providers

$2,045

STANDARD PRICING REGISTER AFTER JUNE 9, 2017 Conference — Pharma/Biotech/Medical Technology

$1,895


$2,095


$2,045


$2,245

ONSITE PRICING Conference — Pharma/Biotech/Medical Technology

$1,995


$2,195


$2,145


$2,345

QUESTIONS? COMMENTS?

Do you have a question or comment that you would like to be addressed at this event? Would you like to get involved as a speaker or discussion leader? Please email Sarah Goldsmith, Senior Conference Director, at [email protected].

GROUP DISCOUNT PROGRAMS  

Offers cannot be combined. Early bird rates do not apply. To find out more on how you can take advantage of these group discounts, call 1-866-207-6528.

Save 25% For every three simultaneous registrations from your company, you will

receive a fourth complimentary registration to the program (must register four at one time). TERMS AND CONDITIONS: By registering for an ExL Events (“ExL”) event, you agree to the following set of terms and conditions listed below: REGISTRATION FEE: The fee includes the conference‚ all program materials‚ and designated continental breakfasts‚ lunches and refreshments. PAYMENT: Make checks payable to ExL Events and write C770 on your check. You may also use Visa, MasterCard, Discover or American Express. Payments must be received in full by the conference date. Any discount applied cannot be combined with any other offer and must be paid in full at the time of order. Parties must be employed by the same organization and register simultaneously to realize group discount pricing options. **Please Note: There will be an administrative charge of $300 to substitute, exchange and/or replace attendance badges with a colleague within five business days of any ExL conference.** CANCELLATION AND REFUND POLICY: If you cancel your registration for an upcoming ExL event, the following policies apply, derived from the Start Date of the event: • Four weeks or more: A full refund (minus a $295 processing fee) or a voucher to another ExL event valid for 12 months from the voucher issue date. • Less than four weeks: A voucher to another ExL event valid for 12 months from the voucher issue date. • Five days or less: A voucher (minus a $395 processing and documentation fee) to another ExL event valid for 12 months from the voucher issue date. To receive a refund or voucher, please email [email protected] or fax your request to 888-2216750. CREDIT VOUCHERS: Credit vouchers are valid for 12 months from date of issue. Credit vouchers are valid toward one (1) ExL event of equal or lesser value. If the full amount of said voucher is not used at time of registration, any remaining balance is not applicable now or in the future. Once a credit voucher has been applied toward a future event, changes cannot be made. In the event of cancellation on the attendees’ behalf, the credit voucher will no longer be valid.

Save 15% Can only send three? You can still save 15% off of each registration.

ExL Events does not and is not obligated to provide a credit voucher to registered attendee(s) who do not attend the event they registered for unless written notice of intent to cancel is received and confirmed prior to the commencement of the event. SUBSTITUTION CHARGES: There will be an administrative charge of $300 to substitute, exchange and/ or replace attendee badges with a colleague occurring within five business days of the conference. ExL Events reserves the right to cancel any conference it deems necessary and will not be responsible for airfare‚ hotel or any other expenses incurred by registrants. ExL Events’ liability is limited to the conference registration fee in the event of a cancellation and does not include changes in program date‚ content‚ speakers and/or venue. *The opinions of ExL’s conference speakers do not necessarily reflect those of the companies they represent, nor ExL Events. Please Note: Speakers and agenda are subject to change without notice. In the event of a speaker cancellation, significant effort to find a suitable replacement will be made. The content in ExL slide presentations, including news, data, advertisements and other information, is provided by ExL’s designated speakers and is designed for informational purposes for its attendees. It is NOT INTENDED for purposes of copywriting or redistribution to other outlets without the express written permission of ExL’s designated speaking parties. Neither ExL nor its content providers and/or speakers and attendees shall be liable for any errors, inaccuracies or delays in content, or for any actions taken in reliance thereon. EXL EVENTS EXPRESSLY DISCLAIMS ALL WARRANTIES, EXPRESSED OR IMPLIED, AS TO THE ACCURACY OF ANY CONTENT PROVIDED, OR AS TO THE FITNESS OF THE INFORMATION FOR ANY PURPOSE. Although ExL makes reasonable efforts to obtain reliable content from third parties, ExL does not guarantee the accuracy of, or endorse the views or opinions given by any third-party content provider. ExL presentations may point to other websites that may be of interest to you, however ExL does not endorse or take responsibility for the content on such other sites.

 WAYS TO REGISTER 

866-207-6528



www.exlevents.com/PR

@

[email protected]



ExL Events 494 8th Ave, Fourth Floor New York, NY 10001

Method of Payment: Card Type:

□ □ MasterCard □ □ Visa □ □

Card Number:

Name on Card:

Discover □

□ AMEX

Exp. Date: CVV:

Signature: Please contact me:

□ □

888-221-6750



□ Check □ Credit Card

Make checks payable to ExL Events.

□ Yes! Register me for the conference and networking dinner.

I'm interested in marketing opportunities at this event. I wish to receive email updates on ExL Pharma's upcoming events. CONFERENCE CODE: C770

□ Yes! Register me for the conference. Name: Title: Company: Dept.: Address: City:

State:

Zip:

Email: Phone:

Fax:

The ONLY Communications Event for Peer Learning and Unparalleled Networking Exclusively for the Life Sciences Community

July 18-19, 2017

PUBLIC RELATIONS

13TH

& COMMUNICATIONS

SUMMIT

Celgene Campus Summit, NJ

PROVIDING A CLEAR PATH FORWARD DURING CHAOTIC TIMES

CONFERENCE CO-CHAIR Julissa Viana Senior Director, Corporate Communications and Global Social Media CELGENE CORPORATION

CONFERENCE CO-CHAIR Wendy Lund Chief Executive Officer GCI HEALTH

OPENING KEYNOTE Mark J. Alles Chief Executive Officer CELGENE CORPORATION

KEYNOTE PRESENTER Ron Cohen Founder, Chief Executive Officer and President ACORDA THERAPEUTICS
